CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,992,000 | +8.1% | 26,050,000 | 0.0% | 0.02% | +11.1% |
| Q2 2022 | $15,725,000 | -15.4% | 26,050,000 | 0.0% | 0.02% | +5.9% |
| Q1 2022 | $18,592,000 | +6.4% | 26,050,000 | 0.0% | 0.02% | +21.4% |
| Q4 2021 | $17,480,000 | -4.3% | 26,050,000 | +4.0% | 0.01% | -12.5% |
| Q3 2021 | $18,264,000 | -2.2% | 25,050,000 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $18,670,000 | -2.5% | 25,050,000 | 0.0% | 0.02% | -11.1% |
| Q1 2021 | $19,155,000 | +14.5% | 25,050,000 | +6.4% | 0.02% | +20.0% |
| Q4 2020 | $16,725,000 | +11.5% | 23,550,000 | +4.4% | 0.02% | 0.0% |
| Q3 2020 | $15,002,000 | +9.3% | 22,550,000 | -4.2% | 0.02% | -6.2% |
| Q2 2020 | $13,727,000 | -5.0% | 23,550,000 | 0.0% | 0.02% | -30.4% |
| Q1 2020 | $14,457,000 | +1.9% | 23,550,000 | +4.4% | 0.02% | +43.8% |
| Q4 2019 | $14,189,000 | +57.6% | 22,550,000 | +5.9% | 0.02% | +45.5% |
| Q3 2019 | $9,005,000 | -18.7% | 21,300,000 | +19.7% | 0.01% | -21.4% |
| Q2 2019 | $11,076,000 | +6.2% | 17,800,000 | +33.8% | 0.01% | +7.7% |
| Q1 2019 | $10,427,000 | +11.6% | 13,300,000 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $9,342,000 | – | 13,300,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|